• Optimizing hiPSC Platelet Differentiation: Study Insights

  2026-09-21

  A 2026 study in Stem Cell Reviews and Reports optimized an embryoid-body-based workflow for producing megakaryocytes and functional platelets from human induced pluripotent stem cells. The protocol shortened differentiation to 19 days, reached 14.9 platelets per input iPSC, and reduced reported costs by 58.3%, while replacing selected cytokines with small molecules.

• ETS1–SENP2 Signaling in Bronchopulmonary Dysplasia

  2026-09-21

  The reference study identifies ETS1 as a transcriptional regulator of mitochondrial quality control in hyperoxia-induced bronchopulmonary dysplasia. Its central finding is that ETS1 promotes SENP2-dependent deSUMOylation and HSPA8-mediated FUNDC1 degradation, thereby restraining excessive mitophagy and preserving lung-cell and tissue integrity.

• Tobramycin Workflows for Resistance Research

  2026-09-20

  Tobramycin supports reproducible broth-microdilution, comparative susceptibility, and antibiotic resistance research workflows. Its water solubility and 30S-targeting mechanism make it especially useful for controlled Gram-negative bacterial assays, while historical comparative data help researchers design informative controls.

• Sisomicin Activity Against Clinical Isolates

  2026-09-19

  Stewart and Bodey evaluated sisomicin against 565 clinical isolates and found activity broadly comparable to gentamicin and Tobramycin, with modest advantages against several important Gram-negative species. The study is valuable as a historical, head-to-head MIC comparison that also illustrates cross-resistance patterns and the importance of isolate selection in aminoglycoside research.

• Nicotinamide Adenine Dinucleotide (NAD+) Workflows

  2026-09-18

  Build more interpretable redox, enzyme-activity, and energy-stress experiments with NAD+ as a controlled cofactor input. This practical guide connects NAD+ handling to AMPK–ULK1 autophagy biology while emphasizing assay controls, workflow timing, and troubleshooting.

• Baicalin Methyl Ester: From Barrier Biology to Translation

  2026-09-18

  Baicalin methyl ester connects P65-centered inflammatory signaling with measurable intestinal barrier outcomes. This thought-leadership guide translates preclinical evidence into practical study design, endpoint selection, formulation strategy, and a realistic roadmap toward translational validation.

• Okadaic acid: PP1/PP2A Workflow Guide

  2026-09-17

  Okadaic acid (A4540) provides a controlled way to inhibit PP2A predominantly at low nanomolar exposure and PP1 at higher exposure, supporting phosphorylation and apoptosis workflows. It should be used with vehicle-matched controls, concentration-response testing, and orthogonal endpoints rather than as a universal phosphatase blocker or stand-alone explanation for cell death.

• Septin4, HIF-1α, and Hypoxic Cardiomyocyte Injury

  2026-09-17

  The reference study identifies Septin4 as a mediator of hypoxia-induced cardiomyocyte injury and proposes that it worsens apoptosis by promoting VHL-dependent ubiquitination and degradation of HIF-1α. Its combination of loss-of-function, gain-of-function, protein-interaction, and pathway analyses provides a mechanistic framework for studying how ubiquitin signaling influences myocardial hypoxia responses.

• Butylhydroxyanisole (BHA): Evidence-Led Assays

  2026-09-16

  Butylated hydroxyanisole (BHA) is more than a generic antioxidant: it is a redox perturbation tool whose value depends on rigorous exposure control and orthogonal validation. This evidence-led guide shows how to interpret BHA in ROS detection, apoptosis, and inflammation research without confusing probe chemistry with biology.

• AMPK, ULK1, and Autophagy Under Energy Stress

  2026-09-16

  The reference study revises the canonical view that AMPK generally activates autophagy during glucose starvation, showing instead that AMPK suppresses ULK1-driven autophagy initiation while protecting the autophagy machinery from caspase-mediated loss. Its findings support a context-dependent model in which AMPK limits energy-intensive autophagy during severe energy stress but preserves the capacity to restore cellular homeostasis.

• CD28–ARS2–PKM Splicing in CD8+ T Cells

  2026-09-15

  The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing in activated CD8+ T cells, favoring PKM2 over PKM1 and enabling flexible glucose metabolism. Its findings connect costimulatory signaling to interferon-γ production and antitumor function through a mechanism that is distinct from canonical CD28–PI3K activation.

• Carrier-Platin and the ROS Storm in Cancer Cells

  2026-09-15

  Liu et al. developed carrier-platin, a poly(amino acid)-based formulation containing ultrasmall platinum nanoparticles that rapidly elevates intracellular reactive oxygen species in cancer cells. The study links this ROS burst to cell death within approximately 30 minutes through a mechanism distinct from classical platinum-induced DNA damage, apoptosis, and ferroptosis.

• Tobramycin: Workflows for Bacterial Assays

  2026-09-14

  Build reproducible Tobramycin susceptibility, mechanism, and resistance experiments around broth microdilution, controlled inocula, and carefully interpreted MIC data. This guide translates historical clinical-isolate methods into practical workflows while separating evidence-backed benchmarks from modern assay recommendations.

• AMG 487: CXCR3 Assay Reliability Guide

  2026-09-14

  This scenario-based guide explains how AMG 487 (SKU B3266) can improve the interpretability of CXCR3 migration, calcium, viability, and macrophage-polarization experiments. It combines potency data, formulation guidance, metabolism considerations, and practical vendor-selection criteria for reproducible laboratory workflows.

• AMPK, ULK1, and Autophagy Under Energy Stress

  2026-09-13

  The reference study overturns the prevailing view that AMPK uniformly activates autophagy during energy shortage. Instead, it shows that AMPK suppresses ULK1-dependent autophagy initiation while protecting autophagy machinery from caspase-mediated degradation, thereby balancing immediate energy conservation with later recovery.

8459 records 1/564 page Next 12345 下5页 Last page